ESAP 2018

The Endocrine Self-Assessment Program (ESAP™) is a self-study curriculum aimed at physicians seeking initial certification or recertification in endocrinology, program directors interested in a testing and training instrument, and clinicians simply wanting a self-assessment and a broad review of endocrinology. ESAP 2018 consists of 120 brand-new multiple-choice questions in all areas of endocrinology, diabetes, and metabolism. There is extensive discussion of each correct answer and references. ESAP is updated annually with new questions. For accessibility for international practitioners, SI units are included.

NEW for 2018!

Assess your clinical knowledge through 3 learning modes:

  • ESAP 2018 Learning Mode: This is the "traditional" ESAP. Answer 120 questions and receive immediate feedback and view the detail answer rationale. This mode must be completed in order to earn CME and MOC.
  • Mock Exam Mode: Perfect for simulating an exam. Retake this mock exam as often as you like and each time the questions will be re-organized. Feedback will be provided after completion of the exam.
  • Topical Learning Mode: Questions are organized by topical area.

Visit the online store to purchase.

Target Audience

ESAP is a self-study curriculum aimed at physicians seeking initial certification or recertification in endocrinology, program directors interested in a testing and training instrument, and clinicians simply wanting a self-assessment and a broad review of endocrinology

Learning Objectives

Upon completion of this educational activity, participants will be able to:

  • Recognize clinical manifestations of endocrine and metabolic disorders and select among current options for diagnosis, management, and therapy.
  • Identify risk factors for endocrine and metabolic disorders and develop strategies for prevention.
  • Evaluate endocrine and metabolic manifestations of systemic disorders.
  • Use existing resources pertaining to clinical guidelines and treatment recommendations for endocrine and related metabolic disorders to guide diagnosis and treatment.

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Professionalism
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
Endocrine Disruptors
General Endocrinology
Hormone Abuse
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Nutrition
Obesity
Surgery
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Activity summary
Available credit: 
  • 40.00 ABIM MOC
  • 40.00 AMA PRA Category 1 Credits
  • 40.00 CME Certificate of Participation
Course opens: 
03/17/2018
Course expires: 
03/31/2021
Pricing: 
Member
250
Non-Member
350
In-Training Member/Early Career Member
199
Rating: 
5

Lisa R. Tannock, MD, Program Chair
Professor of Medicine
Chief, Division of Endocrinology and Molecular Medicine
University of Kentucky and Department of Veterans Affairs

Kristien Boelaert, MD
Reader in Endocrinology Center for Endocrinology, Diabetes, and Metabolism
University of Birmingham

Barbara Gisella Carranza Leon, MD
Assistant Professor of Medicine
Vanderbilt University Medical Center

Stephen Clement, MD
Medical Director, Endocrine Services
Inova Fairfax Hospital

Kathryn McCrystal Dahir, MD
Assistant Professor of Medicine
Division of Endocrinology

Vanderbilt University Medical Center

Thomas W. Donner, MD
Associate Professor of Medicine
Division of Endocrinology, Diabetes, and Metabolism

Johns Hopkins University

Marie Freel, MB, ChB, PhD
Consultant Endocrinologist
Queen Elizabeth University Hospital
Glasgow, United Kingdom

Mimi Hu, MD
Associate Professor
Department of Endocrine Neoplasia and Hormonal Disorders

University of Texas MD Anderson Cancer Center

Michael S. Irwig, MD
Associate Professor
George Washington University

Jacqueline Jonklaas, MD, PhD
Professor
Division of Endocrinology and Metabolism

Georgetown University

Steven Magill, MD, PhD
Associate Professor of Clinical Medicine
Medical College of Wisconsin

Deepika Reddy, MD
Assistant Professor
Division of Diabetes, Endocrinology, and Metabolism
University of Utah Healthcare

Roberto Salvatori, MD
Professor of Medicine
Medical Director, Johns Hopkins Pituitary Center

Johns Hopkins University

Savitha Subramanian, MD
Associate Professor of Medicine
University of Washington

Anand Vaidya, MD, MMSC
Assistant Professor of Medicine
Brigham and Women's Hospital
Harvard Medical School

Corrine Welt, MD
Professor of Medicine
University of Utah School of Medicine

Abbie L. Young, MS, CGC, ELS(D)
Medical Editor

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s ESAP Faculty Working Group.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationship(s): Thomas W. Donner, MD, is a study site principal investigator for Novo Nordisk. Mimi Hu, MD, is a primary investigator for AstraZeneca.  Michael Irwig, MD, was faculty for Medscape. Roberto Salvatori, MD, received grant support from National Institutes of Health and Department of Defense; serves on the advisory board for Pfizer and Ionis Pharmaceutical; is a clinical trial investigator for Pfizer, Novartis, Chiasma, Millendo, and Strongbridge . Savitha Subramanian, MD, receives grant support from Ionis Pharmaceuticals. Corrine Welt, MD, is a writer for UpToDate and a consultant for Novartis.     

The following faculty members reported no relevant financial relationships: Kristien Boelaert, MD; Barbara Gisella Carranza Leon; Stephen Clement, MD; Kathryn Dahir, MD; Marie Freel, MD, PhD; Jacqueline Jonklaas, MD, PhD; Steven Magill, MD, PhD; Deepika Reddy, MD; Lisa R. Tannock, MD and Anand Vaidya, MD.

The medical editor for this program, Abbie L. Young, MS, CGC, ELS(D), reported no relevant financial relationships.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMERS

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

USE OF PROFESSIONAL JUDGMENT:

The educational content in this self-assessment test relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

DRUGS AND DOSAGES:

When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

This activity is not supported by educational grant(s) or other funds from any commercial supporter.

AMA PRA CATEGORY 1 CREDIT (CME) INFORMATION

To receive a maximum of 40.0 AMA PRA Category 1 Credits, participants must complete the online interactive module and activity evaluation located at education.endocrine.org. Participants must achieve a minimum score of 70% to claim CME credit. After initially completing the standard ESAP module, if participants do not achieve a minimum score of 70%, they have the option to change their answers and make additional attempts to achieve a passing score. Learners also have the option to clear all answers and start over. Credit is only available on the standard ESAP learning mode.

METHOD OF PARTICIPATION

This enduring material is presented online and in print format. The estimated time to complete this activity, including review of material, is 40 hours. Participants must achieve a minimum score of 70% to claim CME credit and MOC points. After initially completing the module(s), if participants do not achieve a minimum score of 70%, they have the option to change their answers and make additional attempts to achieve a passing score. Participants also have the option to clear all answers and start over. Credit is only available on the standard ESAP learning mode.

SYSTEM REQUIREMENTS

To complete this activity, participants must have access to a computer or mobile device with an Internet connection and use a major Web browser, such as Internet Explorer 10+, Firefox 32+, Safari, or Google Chrome 37+. In addition, cookies and Javascript must be enabled in the browser’s options.

LAST REVIEW DATE: September 2017

ACTIVITY RELEASE DATE: March 2018

ACTIVITY EXPIRATION DATE: March 31, 2021 (date after which this enduring material is no longer certified for AMA PRA Category 1 Credits and ABIM Medical Knowledge MOC points)

For questions about content or obtaining CME credit or MOC points, please contact the Endocrine Society at http://education.endocrine.org/contact.

Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring material for a maximum of 40.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 40 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Available Credit

  • 40.00 ABIM MOC
  • 40.00 AMA PRA Category 1 Credits
  • 40.00 CME Certificate of Participation

Accreditation Period

Course opens: 
03/17/2018
Course expires: 
03/31/2021

To access ESAP 2018, you must first purchase it through the Endocrine Society online store and then login using your Society login credentials.

Required Hardware/software

To complete this activity, participants must have access to a computer or mobile device with an Internet connection and use a major Web browser, such as Internet Explorer 10+, Firefox 32+, Safari 7+, or Google Chrome 37+. In addition, cookies must be enabled in the browser’s options.